ES8700935A1 - Substained release pharmaceutical capsules. - Google Patents

Substained release pharmaceutical capsules.

Info

Publication number
ES8700935A1
ES8700935A1 ES541394A ES541394A ES8700935A1 ES 8700935 A1 ES8700935 A1 ES 8700935A1 ES 541394 A ES541394 A ES 541394A ES 541394 A ES541394 A ES 541394A ES 8700935 A1 ES8700935 A1 ES 8700935A1
Authority
ES
Spain
Prior art keywords
release pharmaceutical
pharmaceutical capsules
substained release
substained
gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541394A
Other languages
Spanish (es)
Other versions
ES541394A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of ES8700935A1 publication Critical patent/ES8700935A1/en
Publication of ES541394A0 publication Critical patent/ES541394A0/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Abstract

The invention concerns gastrointestinal, pH-independent, sustained-release pharmaceutical unit dosage form comprising a non-compressed mixture of a therapeutic agent and from about 10 to about 60 per cent by weight of a high molecular weight hydroxypropylmethylcellulose, and a method for production thereof in hard gelatin capsules.
ES541394A 1984-03-21 1985-03-20 Substained release pharmaceutical capsules. Expired ES8700935A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59173884A 1984-03-21 1984-03-21

Publications (2)

Publication Number Publication Date
ES8700935A1 true ES8700935A1 (en) 1986-11-16
ES541394A0 ES541394A0 (en) 1986-11-16

Family

ID=24367713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541394A Expired ES8700935A1 (en) 1984-03-21 1985-03-20 Substained release pharmaceutical capsules.

Country Status (13)

Country Link
EP (1) EP0156592A3 (en)
JP (1) JPS61501511A (en)
KR (1) KR850700212A (en)
AU (1) AU4064285A (en)
DK (1) DK529885D0 (en)
ES (1) ES8700935A1 (en)
FI (1) FI854573A0 (en)
GB (1) GB2157169A (en)
GR (1) GR850625B (en)
HU (1) HUT38262A (en)
PT (1) PT80124B (en)
WO (1) WO1985004100A1 (en)
ZA (1) ZA851891B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
SE8601624D0 (en) * 1986-04-11 1986-04-11 Haessle Ab NEW PHARMACEUTICAL PREPARATIONS
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
SI8710406B (en) * 1987-03-11 1998-08-31 Lek Sustained release tablets on the basis of high molecular weight hydroxypropylmethylcellulose and a process for their manufacture
FR2618073B1 (en) * 1987-07-16 1990-09-07 Pf Medicament HYDROPHILIC MATRIX-TYPE TABLETS BASED ON SALBUTAMOL AND THEIR PREPARATION METHOD
IT1222414B (en) * 1987-07-31 1990-09-05 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS CONTAINING TRAPIDIL, THEIR PREPARATION PROCEDURE AND RELATED THERAPEUTIC USE
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
ES2322405T3 (en) 1996-07-08 2009-06-19 Penwest Pharmaceuticals Co. CONTROLLED LIBERATION MATRIX FOR INSOLUBLE DRUGS IN HIGH DOSE.
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
KR20120118031A (en) * 2010-02-12 2012-10-25 닛산 가가쿠 고교 가부시키 가이샤 Extended release preparation
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
WO2014110248A1 (en) * 2013-01-09 2014-07-17 Edgemont Pharmaceuticals Llc Controlled release formulations of lorazepam

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
FR2525474A1 (en) * 1982-04-26 1983-10-28 Roussel Uclaf NEW ORAL PHARMACEUTICAL FORM OF CLOMETACIN
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.

Also Published As

Publication number Publication date
PT80124A (en) 1985-04-01
WO1985004100A1 (en) 1985-09-26
FI854573A (en) 1985-11-20
KR850700212A (en) 1985-12-26
GR850625B (en) 1985-06-17
AU4064285A (en) 1985-10-11
ES541394A0 (en) 1986-11-16
GB2157169A (en) 1985-10-23
DK529885A (en) 1985-11-15
EP0156592A2 (en) 1985-10-02
ZA851891B (en) 1986-10-29
JPS61501511A (en) 1986-07-24
FI854573A0 (en) 1985-11-20
DK529885D0 (en) 1985-11-15
GB8506656D0 (en) 1985-04-17
HUT38262A (en) 1986-05-28
PT80124B (en) 1986-11-14
EP0156592A3 (en) 1987-03-11

Similar Documents

Publication Publication Date Title
ES8700935A1 (en) Substained release pharmaceutical capsules.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
CY1674A (en) 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alcanoic acids,process for their preparation,their pharmaceutical preparation as well their therapeutic use
MY104065A (en) New pharmaceutical preparation
SE8207167L (en) METHOD OF PREPARING THERAPEUTIC COMPOUNDS WITH EXTENDED DELIVERY TIME BASED ON HYDROXYPROPYLMETHYL CELLULOSA
IL65706A (en) Slow release pharmaceutical composition comprising indoramin and its preparation
NZ221805A (en) Oral, solid, controlled release pharmaceutical dosage form; preparatory processes
HUT54490A (en) Process for producing orally administered suspended pharmaceutical compositions
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
IL87080A (en) 4-amino-5-halo 2,n-disubstituted benzamides,their preparation and pharmaceutical compositions containing them
JPS5241214A (en) Method of making preparations for oral administration
IT1150608B (en) PLATINUM-DIAMINE COMPLEXES AND PROCEDURE FOR THEIR PREPARATION AS WELL AS ANTI-CANCER PHARMACEUTICAL FORMULATIONS CONTAINING SUCH COMPLEXES
ES8506616A1 (en) N-aryl-alpha-amino-carboxamides.
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ES2026304A6 (en) Dosage form for administering calcium antagonist.
ES535798A0 (en) PROCESS FOR THE MANUFACTURE OF SPYRO-HYDANTOIN COMPOUNDS.
IL87019A (en) Substituted alkene carboxamides and derivatives, their manufacture and pharmaceutical compositions containing them
IL68619A (en) 11-oxo-11h-pyrido(2,1-h)quinazolinecarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
ES8504166A1 (en) 6,11-Dihydro-11,-oxo-dibenz(b,e)-oxepin derivatives, methods for their preparation, pharmaceutical compositions containing the same and their use as medicaments.
EP0383481A3 (en) Anesthetic oral compositions
DE3164054D1 (en) Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
ZA898274B (en) 2-aminocarboxylic acids and their derivatives,processes for their preparation and their use as medicaments
IT1134457B (en) ALPHA-MERCAPTO PROPIONYLGLYCIN DERIVED FROM THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
ES8307717A1 (en) 2-Methoxyphenyl esters of N-substituted amino acids, a process for their preparation and pharmaceutical compositions containing them